Syndicated sermorelin piece restates GHRH receptor signaling, offers no new data
The article describes cAMP cascades and possible IGF-1 crosstalk in hedged, speculative language without citing any specific study.
PR
By Priya Raman · Science Reporter
Sep 30 21:06 ETSource: Dalton Daily Citizen
The wire
- 01A syndicated item frames sermorelin, the first 29 amino acids of GHRH, as binding pituitary somatotroph GHRH receptors and initiating cAMP signaling linked to growth hormone transcription.
- 02Readers tracking growth-hormone secretagogues will find no trial, dose or endpoint here, only hypothesized links to pulsatility, chronobiology and IGF-1-mediated tissue remodeling.
- 03The piece is written in research-use framing with no citations, sample sizes or sponsor disclosure, and makes no clinical claims that can be verified.
From the source
Read at daltoncitizen.comSermorelin: A Speculative Exploration of Its Molecular Signaling and Research-Oriented Potential
Sermorelin: A Speculative Exploration of Its Molecular Signaling and Research-Oriented Potential
